BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.488,58 PKT +8,29 PKT +0,56 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
03.11.14 Nestlé overweight JP Morgan Chase & Co.
03.11.14 Holcim buy S&P Capital IQ
03.11.14 Zurich Insurance Outperform Credit Suisse Group
03.11.14 UBS Sell Société Générale Group S.A. (SG)
03.11.14 Zurich Insurance Outperform Credit Suisse Group
31.10.14 Holcim buy UBS AG
31.10.14 Novartis Halten Independent Research GmbH
30.10.14 Nestlé Neutral Citigroup Corp.
29.10.14 UBS buy Deutsche Bank AG
29.10.14 Novartis Hold Deutsche Bank AG
29.10.14 UBS overweight JP Morgan Chase & Co.
29.10.14 UBS overweight Morgan Stanley
29.10.14 Swiss Re Neutral UBS AG
28.10.14 Novartis buy S&P Capital IQ
28.10.14 UBS Strong Buy S&P Capital IQ
28.10.14 Givaudan Sell Goldman Sachs Group Inc.
27.10.14 UBS buy Deutsche Bank AG
24.10.14 UBS Equal-Weight Morgan Stanley
24.10.14 UBS Underweight JP Morgan Chase & Co.
24.10.14 ABB (Asea Brown Boveri) Outperform Credit Suisse Group
24.10.14 UBS Neutral UBS AG
23.10.14 ABB (Asea Brown Boveri) Neutral UBS AG
23.10.14 Novartis buy UBS AG
23.10.14 UBS buy S&P Capital IQ
23.10.14 UBS neutral Independent Research GmbH
23.10.14 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
22.10.14 Holcim buy Kepler Cheuvreux
22.10.14 ABB (Asea Brown Boveri) Halten Independent Research GmbH
22.10.14 Zurich Insurance Neutral JP Morgan Chase & Co.
22.10.14 Swiss Re Underweight JP Morgan Chase & Co.
22.10.14 Roche buy Citigroup Corp.
22.10.14 ABB (Asea Brown Boveri) buy S&P Capital IQ
20.10.14 Givaudan buy UBS AG
20.10.14 Roche overweight JP Morgan Chase & Co.
17.10.14 Nestlé Neutral Goldman Sachs Group Inc.
17.10.14 Nestlé overweight Morgan Stanley
17.10.14 Nestlé Halten Independent Research GmbH
17.10.14 Nestlé Neutral BNP PARIBAS
17.10.14 Nestlé Neutral UBS AG
16.10.14 Roche Hold S&P Capital IQ